Is Diarrhoea a Side Effect of Mounjaro — and How Serious Is It?

Diarrhoea is listed as a common side effect of Mounjaro in both the NHS medicines information and the medicine's Summary of Product Characteristics.
GI side effects (including diarrhoea, nausea and constipation) are most likely during the early weeks or after each dose step, and often settle as your body adjusts.
Severe or persistent abdominal pain, particularly pain that radiates to your back, requires urgent medical attention; the MHRA highlighted acute pancreatitis as a known risk of GLP-1 medicines in January 2026.
You can report any suspected side effect, including gastrointestinal symptoms that concern you, through the MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk.

Yes, diarrhoea is a recognised side effect of Mounjaro (tirzepatide). It appears in clinical trial data and in the medicine's official prescribing information, and it tends to be most noticeable in the first few weeks of treatment or after a dose increase. For most people it is mild, temporary, and manageable — but knowing what to expect, and what counts as a reason to seek help, matters. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses suitability, including your personal risk profile for side effects, before any treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence actually says about Mounjaro and loose stools, and what it doesn't

The misconception worth correcting first: diarrhoea doesn't mean the medicine isn't working

A common worry is that loose stools signal something has gone wrong, an intolerance, an overdose, or treatment that simply isn't right for you. That's understandable, but it misreads what's happening. Mounjaro slows gastric emptying and changes how the gut handles food. That shift in pace and signalling is precisely what reduces appetite and blood sugar; the gastrointestinal adjustment that can produce diarrhoea in some people is a consequence of the same mechanism, not a sign of failure.

The NHS medicines page for tirzepatide lists diarrhoea alongside nausea, vomiting, constipation and indigestion as common side effects, meaning they affect at least one in ten people. They are typically most pronounced in the first two to four weeks and again after each dose increase, then settle. That pattern is consistent across the SURMOUNT clinical trial programme, which enrolled thousands of adults over 72 weeks.

If symptoms are disruptive but not alarming, the usual practical steps (staying well hydrated, eating smaller portions more slowly, reducing high-fat meals during dose transitions) tend to help. How much any of this applies to your specific situation is a conversation for your prescriber, not a protocol to follow from a webpage. You can read more about the full range of Mounjaro side effects and how they tend to present.

How often does diarrhoea actually occur, and does it get worse at higher doses?

Trial data show that GI side effects, including diarrhoea, do occur more frequently at higher doses of tirzepatide. In SURMOUNT-1, participants on 15 mg reported diarrhoea more often than those on 5 mg. That doesn't mean everyone on a higher dose experiences it (individual variation is large) but it does explain why the starting dose of 2.5 mg exists. The first few months of treatment are calibrated to let your digestive system adapt gradually before the dose climbs.

Most episodes are loose rather than severely watery, brief rather than prolonged, and resolve without any specific treatment. If you want a closer look at how Mounjaro side effects like diarrhoea tend to develop and what typically helps, our dedicated page covers the detail. Electrolyte drinks are fine if symptoms are more than mild; your prescriber can advise whether oral rehydration salts are appropriate for you.

Diarrhoea that persists across several weeks at a stable dose, or that is severe enough to affect daily life or cause signs of dehydration, is worth raising with your prescribing team rather than waiting out. The detailed guide to diarrhoea on Mounjaro covers practical management in more depth, and our tirzepatide-specific side-effect information discusses the mechanism further.

When diarrhoea is a reason to get medical help, not to manage at home

Most of what Mounjaro causes in the gut is a nuisance rather than a danger. There are exceptions, and it is important to name them clearly.

Severe diarrhoea accompanied by vomiting can lead to dehydration quickly, which in turn can affect kidney function. If you cannot keep fluids down for more than 24 hours, feel faint or dizzy, produce very little urine, or have a racing heart, contact NHS 111 or your GP the same day rather than waiting.

Separately, and more urgently: severe, persistent stomach pain (especially pain that reaches through to your back) is not typical diarrhoea. The MHRA's Drug Safety Update of January 2026 confirmed acute pancreatitis as a known but infrequent serious risk with GLP-1 medicines including tirzepatide. If you experience that kind of pain, with or without vomiting, treat it as a reason to seek urgent medical assessment. Go to A&E or call 999 if the pain is sudden and severe.

Any side effect that concerns you can be reported directly to the MHRA via the Yellow Card scheme, this is how the regulator monitors medicines in real-world use, and patient reports genuinely contribute to drug safety surveillance. You can find a broader overview of what to watch for across all Mounjaro side effects on a dedicated page.

How our prescribers approach this in practice

Side effects are not a topic that gets skipped in a rush to approve treatment. At nume, a GPhC-registered Independent Prescriber reads your consultation (a real clinician, not an automated filter) and considers your full medical picture before anything is prescribed. That includes relevant history that might affect how you tolerate GI side effects: conditions like IBS, inflammatory bowel disease, or medicines that already affect gut motility.

If you start treatment and diarrhoea becomes disruptive, aftercare is available seven days a week. A question our prescribers hear regularly is whether the dose should be paused or a titration step repeated; those decisions are made individually, on clinical grounds, not on a fixed schedule. You can read about what Mounjaro is and how the treatment process works on the Mounjaro information page, and explore all available weight-loss treatments at our treatment overview. If you'd like to discuss your specific situation with our clinical team, starting a free consultation is the first step.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions